Emergence of TNIK Inhibitors in Cancer Therapeutics

Cancer Science - United States
doi 10.1111/cas.13203
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Histone Deacetylase Inhibitors as Cancer Therapeutics

Annals of Translational Medicine
Medicine
2016English

Plant Protease Inhibitors in Therapeutics-Focus on Cancer Therapy

Frontiers in Pharmacology
Pharmacology
2016English

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Role of P-Glycoprotein Inhibitors in Ceramide-Based Therapeutics for Treatment of Cancer

Biochemical Pharmacology
BiochemistryPharmacology
2017English

Protein Methyltransferase Inhibitors as Precision Cancer Therapeutics: A Decade of Discovery

Philosophical Transactions of the Royal Society B: Biological Sciences
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2018English

Mechanistic Target of Rapamycin Inhibitors: Successes and Challenges as Cancer Therapeutics

2019English

Targeted Secretion Inhibitors—Innovative Protein Therapeutics

Toxins
MutagenesisToxicologyHealth
2010English

Targeting Microenvironment in Cancer Therapeutics

Oncotarget
Oncology
2016English

Inhibitors of Connexin and Pannexin Channels as Potential Therapeutics

Pharmacology and Therapeutics
Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy